Insider Trading Activity Neurocrine Biosciences, Inc. (NASDAQ:NBIX) – Insider Sold 15,354 shares of Stock

ME Staff
-
0

Insider Trading Activity For Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Dimitri E Grigoriadis , Insider of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) reportedly Sold 15,354 shares of the company’s stock at an average price of 55 for a total transaction amount of $844,470.00 SEC Form

Insider Trading History For Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

  • On 6/21/2013 Dimitri E Grigoriadis, Insider, sold 46,837 with an average share price of $12.51 per share and the total transaction amounting to $585,930.87.View SEC Filing
  • On 6/27/2013 Haig P Bozigian, Insider, sold 8,000 with an average share price of $13.00 per share and the total transaction amounting to $104,000.00.View SEC Filing
  • On 6/28/2013 Christopher Flint Obrien, Insider, sold 11,357 with an average share price of $13.33 per share and the total transaction amounting to $151,388.81.View SEC Filing
  • On 7/12/2013 Christopher Flint Obrien, Insider, sold 5,000 with an average share price of $14.50 per share and the total transaction amounting to $72,500.00.View SEC Filing
  • On 8/5/2013 Timothy Coughlin, CFO, sold 10,965 with an average share price of $14.99 per share and the total transaction amounting to $164,365.35.View SEC Filing
  • On 8/5/2013 Haig Bozigian, Insider, sold 11,001 with an average share price of $15.00 per share and the total transaction amounting to $165,015.00.View SEC Filing
  • On 8/6/2013 W Thomas Mitchell, Director, sold 1,531 with an average share price of $14.70 per share and the total transaction amounting to $22,505.70.View SEC Filing

    • Analyst Ratings For Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
    These are 1 Hold Rating, 16 Buy Ratings .
    The current consensus rating for Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is Buy (Score: 2.94) with a consensus target price of $68.25 , a potential (26.44% upside)

    Analyst Ratings History For Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

    • On 11/2/2015 Nomura Boost Price Target of rating Buy with a price target of $34.00 to $43.00
    • On 11/22/2016 Citigroup Inc. Initiated Coverage of rating Market Perform with a price target of $55.00
    • On 1/19/2017 Deutsche Bank AG Reiterated Rating Buy with a price target of $65.00 to $62.00
    • On 1/27/2017 CIBC Upgraded rating Market Perform to Outperform
    • On 2/10/2017 ICAP Reiterated Rating Outperform with a price target of $55.00
    • On 2/16/2017 HC Wainwright Boost Price Target of rating Positive with a price target of $80.00 to $100.00
    • On 3/7/2017 Cantor Fitzgerald Reiterated Rating Overweight with a price target of $80.00

    Recent Trading Activity for Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
    Shares of Neurocrine Biosciences, Inc. closed the previous trading session at 53.98 down -0.09 -0.17% with 705,126 shares trading hands.